Skip to search formSkip to main contentSkip to account menu

Fosamax

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
—Fosamax (Alendronate) is an approved drug widely prescribed for osteoporosis treatment and other bone damaging diseases. Fosamax… 
2010
2010
A 90-year old woman attended a department of Oral and Maxillofacial Surgery with a tongue that had been painful for at least 3… 
Review
2009
Review
2009
The reluctance of physicians to use estrogens in women with hormone responsive disorders is a tragic result of the 2002 WHI study… 
2009
2009
A New York judge has revealed internal Merck discussions about a possible link between its widely prescribed drug and dead jaw… 
2008
2008
VOLUME 26 NUMBER 4 APRIL 2008 NATURE BIOTECHNOLOGY Most osteoporosis therapies act by inhibiting osteoclast-mediated bone… 
1998
1998
Alendronate (Fosamax, Merck Sharp & Dohme) is an aminobisphosphonate which inhibits bone turnover by suppressing the activity of… 
1998
1998
L'alendronate de sodium (Fosamax®, Merck Sharp & Dohme) est un aminobisphosphonate dote d'une activite inhibitrice sur l'activite…